Risultati della ricerca - Thorbald van Hall
- Mostra 1 - 20 risultati su 55
- Vai alla pagina seguente
-
1
Alternative Antigen Processing for MHC Class I: Multiple Roads Lead to Rome di Cláudia C. Oliveira, Thorbald van Hall
Pubblicazione 2015Revisão -
2
TEIPP antigens for T-cell based immunotherapy of immune-edited HLA class Ilow cancers di Koen A. Marijt, Elien M. Doorduijn, Thorbald van Hall
Pubblicazione 2018Revisão -
3
The NKG2A–HLA-E Axis as a Novel Checkpoint in the Tumor Microenvironment di Linda Borst, Sjoerd H. van der Burg, Thorbald van Hall
Pubblicazione 2020Revisão -
4
Future Challenges in Cancer Resistance to Immunotherapy di Marit J van Elsas, Thorbald van Hall, Sjoerd H. van der Burg
Pubblicazione 2020Revisão -
5
-
6
-
7
-
8
Therapeutic cancer vaccines di Cornelis J.M. Melief, Thorbald van Hall, Ramon Arens, Ferry Ossendorp, Sjoerd H. van der Burg
Pubblicazione 2015Revisão -
9
Design of Agonistic Altered Peptides for the Robust Induction of CTL Directed towards H-2Db in Complex with the Melanoma-Associated Epitope gp100 di Marianne J.B. van Stipdonk, Daniel Badia-Martinez, Marjolein Sluijter, Rienk Offringa, Thorbald van Hall, Adnane Achour
Pubblicazione 2009Artigo -
10
-
11
Differential Influence on Cytotoxic T Lymphocyte Epitope Presentation by Controlled Expression of Either Proteasome Immunosubunits or Pa28 di Thorbald van Hall, Alice J.A.M. Sijts, Marcel Camps, Rienk Offringa, Cornelis J.M. Melief, Peter‐M. Kloetzel, Ferry Ossendorp
Pubblicazione 2000Artigo -
12
-
13
-
14
The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma di Mehrdad Talebian Yazdi, Sander van Riet, Annemarie van Schadewijk, Marta Fiocco, Thorbald van Hall, Christian Taube, Pieter S. Hiemstra, Sjoerd H. van der Burg
Pubblicazione 2015Artigo -
15
CD4+ T Cell and NK Cell Interplay Key to Regression of MHC Class Ilow Tumors upon TLR7/8 Agonist Therapy di Elien M. Doorduijn, Marjolein Sluijter, Daniela Salvatori, Serenella Silvestri, Saskia Maas, Ramon Arens, Ferry Ossendorp, Sjoerd H. van der Burg, Thorbald van Hall
Pubblicazione 2017Artigo -
16
-
17
Cancer vaccines compensate for the insufficient induction of protective tumor-specific immunity of CD3 bispecific antibody therapy di Jim Middelburg, Gaby Schaap, Marjolein Sluijter, Katy A. Lloyd, Vitalijs Ovcinnikovs, Janine Schuurman, Sjoerd H. van der Burg, Kristel Kemper, Thorbald van Hall
Pubblicazione 2025Artigo -
18
CD3-Bispecific Antibody Therapy Turns Solid Tumors into Inflammatory Sites but Does Not Install Protective Memory di Hreinn Benonisson, Işıl Altıntaş, Marjolein Sluijter, Sandra Verploegen, Aran F. Labrijn, Danita H. Schuurhuis, Mischa Houtkamp, J. Sjef Verbeek, Janine Schuurman, Thorbald van Hall
Pubblicazione 2018Artigo -
19
-
20
Invasive margin tissue-resident macrophages of high CD163 expression impede responses to T cell-based immunotherapy di Marit J van Elsas, Camilla Labrie, Anders Etzerodt, Pornpimol Charoentong, Jordi J C van Stigt Thans, Thorbald van Hall, Sjoerd H. van der Burg
Pubblicazione 2023Artigo
Strumenti per la ricerca:
Soggetti correlati
Immunology
Immune system
Cancer research
Biology
Medicine
CD8
Biochemistry
Antigen
Immunotherapy
In vitro
Cancer
T cell
Cytotoxic T cell
Internal medicine
Genetics
Cell biology
Major histocompatibility complex
MHC class I
Tumor microenvironment
Receptor
Antibody
Cancer immunotherapy
Gene
Antigen presentation
Chemistry
Antigen processing
Blockade
Immune checkpoint
Macrophage
Melanoma